Company: LNAI
Filing Date: 2025-07-09
Form Type: 8-K
Source: 0001731122-25-000948
Chunk: 2

Company: Lunai Bioworks Inc.
Filing Date: 2025-07-09
Form: 8-K
Item: Item 3.02
Chunk 2
---
Item 3.02 Unregistered Sales of Equity Securities.

The information set forth in Item 1.01 is incorporated herein by reference.

The issuance of the convertible notes and the shares of common stock are
being made in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, and/or
Regulation D. The Holders are accredited investors acquiring the shares for investment purposes and are existing investors of the Company.

Item 7.01
Regulation FD Disclosure.

On July 9, 2025, the Company issued a press release announcing the exchange
of $9.7 million in senior debt into convertible notes, which the Holders elected to convert into approximately 53.6 million shares of
common stock. A copy of the press release is furnished as Exhibit 99.4 to this Current Report on Form 8-K.

The information under this Item 7.01 and Exhibit 99.4 is being furnished
and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of
that section, nor shall it be incorporated by reference into any filing under the Securities Act or Exchange Act, except as shall be expressly
set forth by specific reference in such a filing.

Item 9.01
Financial Statements and Exhibits.

  Exhibit No.      Description                                         
 ───────────────────────────────────────────────────────────────────────
         99.1      F orm of Exchange Agreement                         
         99.2      Form of Convertible Note                            
         99.3      Form of Conversion Notice                           
         99.4      Press Release of Renovaro Inc. dated July 9, 2025.  

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

  RENOVARO INC.                                      
  By:                /s/ David Weinstein             
                     Name: David Weinstein           

Date: July 9, 2025